Interstitial lung disease clinics for the management of idiopathic pulmonary fibrosis: a potential advantage to patients
- 1 September 1999
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 18 (9) , 884-890
- https://doi.org/10.1016/s1053-2498(99)00050-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Idiopathic Pulmonary Fibrosis and CyclosporineChest, 1998
- Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Survival in Patients With Cryptogenic Fibrosing AlveolitisChest, 1998
- Hospital care for adults with cystic fibrosis: an overview and comparison between special cystic fibrosis clinics and general clinics using a patient questionnaire.Thorax, 1994
- The Predictive Value of Appearances on Thin-section Computed Tomography in Fibrosing AlveolitisAmerican Review of Respiratory Disease, 1993
- Azathioprine Combined with Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Prospective Double-blind, Randomized, Placebo-controlled Clinical TrialAmerican Review of Respiratory Disease, 1991
- Cyclosporin as a treatment for interstitial lung disease of unknown aetiology.Thorax, 1991
- Advanced cryptogenic fibrosing alveolitis: preliminary report on treatment with cyclosporin ARespiratory Medicine, 1989
- Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.Thorax, 1989
- The prognosis of cryptogenic fibrosing alveolitisThorax, 1972